Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction.
Selvaraj S, Patel S, Sauer AJ, McGarrah RW, Jones P, Kwee LC, Windsor SL, Ilkayeva O, Muehlbauer MJ, Newgard CB, Borlaug BA, Kitzman DW, Shah SJ, Margulies KB, Husain M, Inzucchi SE, McGuire DK, Lanfear DE, Javaheri A, Umpierrez G, Mentz RJ, Sharma K, Kosiborod MN, Shah SH.
Selvaraj S, et al. Among authors: shah sh.
Circ Heart Fail. 2024 Oct 18:e011980. doi: 10.1161/CIRCHEARTFAILURE.124.011980. Online ahead of print.
Circ Heart Fail. 2024.
PMID: 39421941